If you don't test, they will not treat: Impact of stopping preoperative screening for asymptomatic bacteriuria

Utility of Routine Preoperative Urinalysis in Elective Lumbar Spine Fusion Surgery

Study DesignA retrospective cohort study.ObjectiveTo evaluate the utility of routine preoperative urinalysis as a predictor of postoperative complications following elective lumbar fusion surgery (ELFS).MethodsThis study included a retrospective review of patients aged ≥18 years-old who underwent ELFS for degenerative pathology between 2018 to 2022 at a single academic institution. Patients were categorized into 3 groups: No Urinalysis (No-UA), Negative Urinalysis (Negative-UA), and Positive Urinalysis (Positive-UA). A retrospective review of medical records was conducted including patient characteristics and clinical factors of interest. Emergency department (ED) visits and return to the operating room (OR) within 3-months postoperatively were recorded. Statistical analyses were performed using bivariate and multivariate analysis.ResultsA total of 493 patients were included. Despite having higher rates of preoperative antibiotics administered, patients with a positive urinalysis were significantly more likely to present with postoperative urinary tract infections (UTIs) than the No-UA and Negative-UA groups. No significant differences were seen in other types of complications including pneumonia, bacteremia, superficial wound infections, deep wound infections, and wound dehiscence between the 3 groups. Additionally, rates of return to OR, return to ED, reinsertion of foley catheters, duration of indwelling catheterization, and hospital length of stay had no significant differences between the groups.ConclusionThis study suggests there may be a limited role in performing routine preoperative urinalysis prior to ELFS. This study may help further improve preoperative assessment guidelines and assist with patient counseling and considerations prior to elective lumbar fusion surgery.

Pseudomonas aeruginosa Isolation from Urine Culture in Hospitalised Patients: Incidence of Complicated Urinary Tract Infections and Asymptomatic Bacteriurias and Impact on Treatment of the EUCAST 2020 Update

Background. Urinary tract infections (UTIs) and asymptomatic bacteriurias (ABU) represent a large field of interest for antimicrobial stewardship programmes especially after 2020 EUCAST update in antimicrobial susceptibility testing interpretation and the possible related increase in carbapenems' prescription rate. The aim of this study was to evaluate the impact of the 2020 EUCAST update on antibiotic prescription in UTI due to Pseudomonas aeruginosa organism and their characteristics. Methods. A retrospective observational study. We enrolled all the patients with P. aeruginosa isolation from urine, admitted to our hospital from 2018 to 2021. We compared demographic, clinical, and microbiological characteristics and treatment between cases before 2020 EUCAST update (period A, 2018-2019) and after it (period B, 2020-2021). Results. A total of 643 cases was analysed, 278 in period A and 365 in period B; 65% were ABU. Carbapenems' prescription rate significantly increased in period B when considering ABU alone (21.4% vs. 41%, p = 0.016) and all the treated cases (treated ABU and UTI; 27.8% vs. 41.4%, p = 0.013); anti-Pseudomonas cephalosporins prescription significantly decreased in period B when considering ABU alone (15.7% vs. 3.6%, p = 0.021), UTI alone (20.7% vs. 5.9%, p = 0.009) and all the treated cases (18.5% vs. 5.9%, p = 0.001). Conclusions. The 2020 EUCAST update could have contributed to an increase in carbapenem prescriptions. UTI and ABU represent a large field of interest for stewardship interventions both from a diagnostic and therapeutic point of view.

When antimicrobial stewardship begins with microbiological test requests: the case of asymptomatic bacteriuria

PURPOSE OF REVIEW

We aim to review the rationale, methods, and experiences with diagnostic stewardship targeted at urinary tract infection (UTI) and related urinary syndromes.

RECENT FINDINGS

In the last 18 months, several articles have demonstrated the impact of diagnostic stewardship interventions at limiting inappropriate diagnosis of UTIs or inappropriate antibiotic-prescribing, targeting the urinary tract. Antimicrobial stewardship programs may create and implement interventions at the point of urine test ordering, urine test resulting, or at the point of prescribing antibiotics after results have returned. Specific design and implementation of stewardship interventions depends on context. To maximize their impact, interventions should be accompanied by education and garner buy-in from providers.

SUMMARY

Diagnostic stewardship can decrease unnecessary antibiotics and inappropriate diagnosis of UTI with multifaceted interventions most likely to be effective. Remaining questions include how to reduce ASB treatment in new populations, such as those with immune compromise, and persistent unknowns regarding UTI diagnosis and diagnostics.

Reducing Treatment of Asymptomatic Bacteriuria: What Works?

Asymptomatic bacteriuria is common, but usually benign. Inappropriate antimicrobial treatment of asymptomatic bacteriuria contributes to negative antimicrobial outcomes. Optimizing antimicrobial use for bacteriuria is a component of antimicrobial stewardship programs and includes key practices of dissemination and implementation of guidelines, laboratory practices which support stewardship, and programs to monitor and implement optimal antimicrobial treatment for urinary infection. These activities vary in their effectiveness, costs, and complexity to institute. Stewardship strategies targeting unique populations with a high prevalence of bacteriuria and for whom symptom assessment is not straightforward need to be further developed and evaluated to support optimal stewardship.